Search
Zoniporide
go.drugbank.com/drugs/DB20312ExperimentalZoniporide is a small molecule drug. The usage of the INN stem '-poride' in the name indicates that Zoniporide is a Na+/H+ antiport inhibitor.
Bretazenil
go.drugbank.com/drugs/DB21038ExperimentalBretazenil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Bretazenil is a benzodiazepine receptor antagonist/agonist.
Prinoxodan
go.drugbank.com/drugs/DB21318ExperimentalPrinoxodan is a small molecule drug. The usage of the INN stem '-dan' in the name indicates that Prinoxodan is a cardiac stimulant, pimobendan derivative.
Tanuxiciclib
go.drugbank.com/drugs/DB21504ExperimentalTanuxiciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Tanuxiciclib is a cyclin dependant kinase inhibitor.
Asnuciclib
go.drugbank.com/drugs/DB21530ExperimentalAsnuciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Asnuciclib is a cyclin dependant kinase inhibitor.
Neracorvir
go.drugbank.com/drugs/DB21630ExperimentalNeracorvir is a small molecule drug. The usage of the INN stem '-corvir' in the name indicates that Neracorvir is a core protein (Cp) inhibitor.
Tacaciclib
go.drugbank.com/drugs/DB21644ExperimentalTacaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Tacaciclib is a cyclin dependant kinase inhibitor.
Fovinaciclib
go.drugbank.com/drugs/DB21721InvestigationalFovinaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Fovinaciclib is a cyclin dependant kinase inhibitor.
Zeprumetostat
go.drugbank.com/drugs/DB21740InvestigationalZeprumetostat is a small molecule drug. The usage of the INN stem '-metostat' in the name indicates that Zeprumetostat is a histone N-methyltransferase inhibitor.
Tavapadon
go.drugbank.com/drugs/DB14899Investigationalin Healthy Subjects). … Tavapadon is under investigation in clinical trial NCT02262767 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride